AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...
Nearly 6,500 Arizona children have applied for the new universal vouchers to attend private and parochial schools at taxpayer expense. And it appears the vast majority are students whose parents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results